Need help? Reach out to us
Back to library

Healthcare and pharma

Sandoz India Pharmacovigilance Analyst Interview: Rounds, Questions and Preparation

For Pharmacovigilance Analyst roles at companies like Sandoz India

Share with friends

Preparing together? Send them this role's questions.

https://www.cynchrony.in/library/sandoz-india-pharmacovigilance-analyst

What the job involves

A Pharmacovigilance (PV) Analyst at a company like Sandoz India monitors the safety of medicines after they are marketed. Day to day, they triage and assess individual case safety reports (ICSRs), code adverse events using MedDRA, perform causality and seriousness assessments, and support aggregate reporting such as PSURs and signal detection. The role requires strict adherence to global regulations, timelines, and quality standards.

Role and Technical Knowledge

  1. 1

    What is an ICSR and what are the minimum criteria for a valid case?

    An ICSR is an individual case safety report. A valid case requires an identifiable patient, a suspect drug, an adverse event, and a reporter. Mention that all four elements are needed for a case to be considered valid.

  2. 2

    Explain the difference between a serious and a non-serious adverse event, with examples.

    A serious AE results in death, is life-threatening, requires hospitalization or prolongs it, causes disability, is a congenital anomaly, or is medically important. Non-serious events do not meet these criteria. Give clear examples like rash vs anaphylaxis.

  3. 3

    What are the regulatory timelines for reporting ICSRs to authorities?

    For marketed products, serious unexpected cases must be reported within 15 calendar days, and non-serious cases within 90 days. For clinical trial cases, serious unexpected suspected adverse reactions (SUSARs) have 7 or 15 day timelines depending on fatality. Mention ICH E2A and E2D.

  4. 4

    How do you code an adverse event using MedDRA?

    Explain that you select the most specific Lowest Level Term (LLT) that matches the reported event, then map it to a Preferred Term (PT) and System Organ Class (SOC). Mention that you should not diagnose or infer beyond the reporter's words.

Practical Scenarios

  1. 5

    You receive a case where the patient took multiple medications and the event is unclear. How do you handle it?

    Discuss the need to gather more information from the reporter, assess temporal relationship, use causality assessment tools, and document your reasoning. Highlight that you would not assume causality without evidence.

  2. 6

    A case is missing the patient's age and the reporter's contact details. What do you do?

    Explain that you would attempt to follow up to obtain missing information. If the case remains invalid after follow-up, it may not be reportable, but you must document the follow-up attempts and the rationale.

  3. 7

    How would you prioritize your work if you have multiple cases with different submission deadlines?

    Prioritize by regulatory timeline: 7-day and 15-day cases first, then 90-day cases. Also consider severity and company SOPs. Mention using a tracker or safety database to manage deadlines.

  4. 8

    What is signal detection and what would you do if you notice a new adverse event pattern?

    Signal detection is the process of looking for new or changing patterns of adverse events. If you notice a pattern, you should escalate it through the appropriate channel, document your observation, and support further evaluation by the signal management team.

Behavioural and Situational

  1. 9

    Tell me about a time you had to follow a strict rule or process even when it was inconvenient.

    Use the STAR method. Highlight your understanding of why compliance matters in healthcare, and how you communicated or adapted without cutting corners.

  2. 10

    Describe a situation where you made a mistake or missed a detail. How did you handle it?

    Be honest and show accountability. Explain how you identified the error, corrected it, and put a check in place to prevent recurrence. Emphasize transparency in PV.

  3. 11

    How do you handle working under pressure with tight deadlines?

    Give an example of prioritizing tasks, staying organized, and communicating with your team. Mention that in PV, deadlines are regulatory and non-negotiable, so planning is key.

  4. 12

    Why do you want to work in pharmacovigilance, and why this company?

    Show genuine interest in patient safety and drug safety monitoring. Mention the company's reputation in generics or biosimilars, and how the role aligns with your long-term goals in healthcare.

HR and Compliance

  1. 13

    What do you know about Good Pharmacovigilance Practice (GVP) and why is it important?

    GVP is a set of guidelines ensuring the safe and effective use of medicines. It covers roles, processes, and quality systems. Explain that it ensures patient safety and regulatory compliance.

  2. 14

    How would you handle a situation where you are asked to do something that violates a regulation?

    State clearly that you would not compromise on compliance. You would raise the concern with your supervisor or the quality/compliance team, and document the issue. Patient safety and integrity come first.

  3. 15

    Are you comfortable with rotational shifts or working on weekends if required?

    Be honest about your flexibility. If you are open, say so and explain that you understand global PV operations may require coverage across time zones. If not, discuss alternative arrangements.

  4. 16

    Where do you see yourself in 3 to 5 years in pharmacovigilance?

    Show a realistic progression, such as moving from analyst to senior analyst or into quality, signal management, or aggregate reporting. Mention continuous learning and certifications like PV courses.

Ready to try it for real?

Take a timed test or talk through a mock interview for this role, then see your scores.

This is practice material for Pharmacovigilance Analyst roles, written with AI. It is not a list of questions Sandoz India or any other company has asked.